[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337712-105":59,"doc-detail-337712-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","drug-resistance-mechanisms-and-treatment-strategies-mediated-by-ubiquitin-specific-proteases-usps-in-cancers-review-and-therapeutic-options","Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers - review and therapeutic options","","Drug resistance limits the effectiveness of cancer therapies and drives the need for novel therapeutic targets. Ubiquitin-specific proteases (USPs), a key class of deubiquitinating enzymes, regulate protein deubiquitination and influence resistance across chemotherapy, targeted therapy, immunotherapy, and radiotherapy. This review details how USPs shape DNA damage repair, apoptosis, cancer stem cell traits, immune evasion, and other essential cancer biology. It also discusses the therapeutic value of USP inhibitors, which can sensitize cancer cells to anti-cancer drugs, supporting combination strategies to overcome resistance and improve patient outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/drug-resistance-mechanisms-and-treatment-strategies-mediated-by-ubiquitin-specific-proteases-usps-in-cancers-review-and-therapeutic-options/337712/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/drug-resistance-mechanisms-and-treatment-strategies-mediated-by-ubiquitin-specific-proteases-usps-in-cancers-review-and-therapeutic-options/337712.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do USPs play in drug resistance across cancer therapies?","Question",{"text":112,"@type":113},"USPs, as deubiquitinating enzymes, regulate protein deubiquitination and act as key regulators of drug resistance across chemotherapy, targeted therapy, immunotherapy, and radiotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which biological processes are highlighted as influenced by USPs?",{"text":117,"@type":113},"The review emphasizes USPs’ impact on DNA damage repair, apoptosis, cancer stem cell characteristics, immune evasion, and other crucial functions in cancer biology.",{"name":119,"@type":110,"acceptedAnswer":120},"How can USP inhibitors help overcome drug resistance?",{"text":121,"@type":113},"By inhibiting specific USPs, cancer cells can become more susceptible to a range of anti-cancer drugs, and combining USP inhibitors with existing therapies offers a strategy to circumvent resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337712,1790104105,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Gao et al. Molecular Cancer (2024) 23:88 [https://doi.org/10.1186/s12943-024-02005-y](https://doi.org/10.1186/s12943-024-02005-y)  \nMolecular Cancer  \n REVIEW Open Access  \nDrug resistance mechanisms and treatment   strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directionsand therapeutic options  \nHongli Gao1†, Zhuo Xi2†, Jingwei Dai2†, Jinqi Xue1, Xin Guan3, Liang Zhao4*, Zhiguang Chen5* and Fei Xing1*  \nAbstract  \nDrug resistance represents a significant obstacle in cancer treatment, underscoring the need for the discovery of novel therapeutic targets. Ubiquitin-specific proteases (USPs), a subclass of deubiquitinating enzymes, play a pivotal role in protein deubiquitination. As scientific research advances, USPs have been recognized as key regulators of drug resistance across a spectrum of treatment modalities, including chemotherapy, targeted therapy, immunotherapy, and radiotherapy. This comprehensive review examines the complex relationship between USPs and drug resistance mechanisms, focusing on specific treatment strategies and highlighting the influence of USPs on DNA damage repair, apoptosis, characteristics of cancer stem cells, immune evasion, and other crucial biological functions. Additionally, the review highlights the potential clinical significance of USP inhibitors as a means to counter drug resistance in cancer treatment. By inhibiting particular USP, cancer cells can become more susceptible to a variety of anti-cancer drugs. The integration of USP inhibitors with current anti-cancer therapies offers a promising strategy to circumvent drug resistance. Therefore, this review emphasizes the importance of USPs as viable therapeutic targets and offers insight into fruitful directions for future research and drug development. Targeting USPs presents an effective method to combat drug resistance across various cancer types, leading to enhanced treatment strategies and better patient outcomes.  \nKeywords Ubiquitin-specific proteases (USPs), Drug resistance, Immunotherapy, USP inhibitors  \n†Hongli Gao, Zhuo Xi and Jingwei Dai contributed equally to this work.  \n*Correspondence:  \nLiang Zhao [1203517217@qq.com](1203517217@qq.com)[ ](1203517217@qq.com)Zhiguang Chen [Chencmuchenzg@163.com](Chencmuchenzg@163.com)[ ](Chencmuchenzg@163.com)Fei Xing [xingfshengjing@sina.com](xingfshengjing@sina.com)  \n1 Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China  \n2 Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang 110004, China  \n3 Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110004, China  \n4 Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China  \n5 Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Pu","cbCaijS3bIxATMs9","https://ap.wps.com/l/cbCaijS3bIxATMs9","pdf",3597454,41,"English","# Abstract\n# Introduction\n# Drug resistance mechanisms mediated by USPs\n# Treatment strategies and therapeutic options\n# USP inhibitors and clinical implications\n# Future research directions","[{\"question\":\"What role do USPs play in drug resistance across cancer therapies?\",\"answer\":\"USPs, as deubiquitinating enzymes, regulate protein deubiquitination and act as key regulators of drug resistance across chemotherapy, targeted therapy, immunotherapy, and radiotherapy.\"},{\"question\":\"Which biological processes are highlighted as influenced by USPs?\",\"answer\":\"The review emphasizes USPs’ impact on DNA damage repair, apoptosis, cancer stem cell characteristics, immune evasion, and other crucial functions in cancer biology.\"},{\"question\":\"How can USP inhibitors help overcome drug resistance?\",\"answer\":\"By inhibiting specific USPs, cancer cells can become more susceptible to a range of anti-cancer drugs, and combining USP inhibitors with existing therapies offers a strategy to circumvent resistance.\"}]","Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers - review and therapeutic options | PDF",1790020291,103,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d70a6a4695ffeec520b15fbfc2893740.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d126618de455e9c14651407dc378075e.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95e327075c4fc41217861bbb1098f366.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ee56ae1363949aa9198cbc96381e45d.webp",980,1301,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bda2c16cee311636ddfe492a74c12d6.webp",979,1300]